Nanoparticle Contract Manufacturing Market Size is valued at USD 2.4 Bn in 2023 and is predicted to reach USD 4.3 Bn by the year 2031 at a 7.8% CAGR during the forecast period for 2024-2031.
Nanoparticle contract manufacturing refers to the outsourcing of the production of nanoparticles to specialized companies equipped with the expertise, technology, and facilities to create and manipulate particles at the nanoscale (typically between 1 and 100 nanometers in size). Companies looking to reduce production costs are drawn to these manufacturers because of their large-scale operations and economies of scale. Businesses that want to cut expenses frequently opt for contract manufacturing. One of the main reasons why businesses want to simplify their budgets is cost-effectiveness.
Employing nanotechnology to improve drug delivery and efficacy and minimize adverse effects in nanomedicine is a cutting-edge approach to healthcare that is revolutionizing the pharmaceutical sector. Contract manufacturing for nanoparticles is now necessary to satisfy its complex needs. Handling the intricate formulas and exacting control requirements of nanomedicine is made easier by outsourcing to specialized producers. Furthermore, the need for nanomedicine is rising because of the older population and the rise in chronic disorders. This is because nanoparticles have special properties like improved permeability and prolonged circulation, making them ideal for treating complex chronic ailments.
However, the market growth is hampered by the strict regulatory criteria for the safety and health of the nanoparticle contract manufacturing market and the product's inability to prevent fog in environments with dramatic temperature fluctuations or high nanoparticle contract manufacturing because many rules have been created to monitor the quality and efficacy of medications as a result of the pharmaceutical industry's global expansion. In several nations, regulatory agencies have arisen to fulfil the legal needs of drug research. Furthermore, the inflow of R&D capital for creating and commercializing complicated pharmaceuticals via nanoparticle contract manufacturing was constrained by tight rules enacted by multiple governments. Due to the COVID-19 pandemic, which has affected the worldwide market and forced the closure of numerous factories to protect their personnel from contracting the virus, the expansion of the industry may be hindered.
The nanoparticle contract manufacturing market is segmented based on the type of nanoparticles, manufacturing scale, application, and end-user. Based on the type of nanoparticles, the market is segmented into metal nanoparticles, lipid nanoparticles, and others. By manufacturing scale, the market is segmented into commercial, clinical, and pre-clinical. By application, the market is segmented into therapeutics, diagnostics, and vaccines. By end-user, the market is segmented into pharmaceutical companies and biotechnology companies.
The metal nanoparticle contract manufacturing market is expected to hold a major global market share. Metal nanoparticles are the most common type in the nanoparticle contract manufacturing industry because of their unique characteristics and wide range of uses. They are versatile enough to be used in various industries, the most notable being healthcare.
Pharmaceutical companies expected to lead the market due to increased knowledge about pharmaceutical drug delivery systems. The ever-changing life science industry is driving the market. New advancements are raising awareness about pharmaceutical drug delivery systems, especially in countries like the US, Germany, the UK, China, and India.
The North American nanoparticle contract manufacturing market is expected to record the maximum market revenue share in the near future. It can be attributed to because of the rapid development of technology in underdeveloped regions. In addition, Europe is predicted to grow rapidly in the global nanoparticle contract manufacturing market because of significant progress in materials science and nanotechnology. Innovation brought about by these breakthroughs has spurred nanoparticle manufacturing processes.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 2.4 Bn |
|
Revenue Forecast In 2031 |
USD 4.3 Bn |
|
Growth Rate CAGR |
CAGR of 7.8% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Type Of Nanoparticles, Manufacturing Scale, Application, And End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
AstraZeneca, Inc., Evonik Industries AG, Ascendia Pharmaceuticals, Axolabs (LGC Limited), AVANSA Technology & Services, Ardena Holding NV, Cytodiagnostics, Inc., American Elements, Encapsula NanoSciences LLC, Fortis Life Sciences, Hongwu International Group Ltd., MyBiotech, and Nanochemazone, CordenPharma, LSNE Contract Manufacturing, Polymun, TeachNanoIndia, BIOVECTRA, Precision NanoSystems, Emergent BioSolutions and Other Prominent Players |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Nanoparticle Contract Manufacturing Market Snapshot
Chapter 4. Global Nanoparticle Contract Manufacturing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type of Nanoparticles Estimates & Trend Analysis
5.1. by Type of Nanoparticles & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type of Nanoparticles:
5.2.1. Metal Nanoparticles
5.2.2. Lipid Nanoparticles
5.2.3. Others
Chapter 6. Market Segmentation 2: by Manufacturing Scale Estimates & Trend Analysis
6.1. by Manufacturing Scale & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Manufacturing Scale:
6.2.1. Commercial
6.2.2. Clinical
6.2.3. Pre-clinical
Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis
7.1. by Application & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
7.2.1. Therapeutics
7.2.2. Diagnostics
7.2.3. Vaccines
Chapter 8. Market Segmentation 4: by End-user Estimates & Trend Analysis
8.1. by End-user & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-user:
8.2.1. Pharmaceutical Companies
8.2.2. Biotechnology Companies
Chapter 9. Nanoparticle Contract Manufacturing Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanoparticles, 2019-2031
9.1.2. North America Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Manufacturing Scale, 2019-2031
9.1.3. North America Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
9.1.4. North America Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031
9.1.5. North America Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
9.2. Europe
9.2.1. Europe Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanoparticles, 2019-2031
9.2.2. Europe Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Manufacturing Scale, 2019-2031
9.2.3. Europe Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
9.2.4. Europe Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031
9.2.5. Europe Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanoparticles, 2019-2031
9.3.2. Asia Pacific Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Manufacturing Scale, 2019-2031
9.3.3. Asia-Pacific Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
9.3.4. Asia-Pacific Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031
9.3.5. Asia Pacific Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
9.4. Latin America
9.4.1. Latin America Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanoparticles, 2019-2031
9.4.2. Latin America Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Manufacturing Scale, 2019-2031
9.4.3. Latin America Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
9.4.4. Latin America Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031
9.4.5. Latin America Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanoparticles, 2019-2031
9.5.2. Middle East & Africa Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Manufacturing Scale, 2019-2031
9.5.3. Middle East & Africa Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
9.5.4. Middle East & Africa Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031
9.5.5. Middle East & Africa Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. AstraZeneca
10.2.2. Evonik Industries AG
10.2.3. Ascendia Pharmaceuticals
10.2.4. Axolabs (LGC Limited)
10.2.5. AVANSA Technology & Services
10.2.6. Ardena Holding NV.
10.2.7. Cytodiagnostics, Inc.
10.2.8. American Elements
10.2.9. Encapsula NanoSciences LLC
10.2.10. Fortis Life Sciences
10.2.11. Hongwu International Group Ltd.
10.2.12. MyBiotech
10.2.13. Nanochemazone
10.2.14. CordenPharma
10.2.15. LSNE Contract Manufacturing
10.2.16. Polymun
10.2.17. TeachNanoIndia
10.2.18. BIOVECTRA
10.2.19. Precision NanoSystems
10.2.20. Emergent BioSolutions
10.2.21. Other Prominent Players
10.2.22. Other Prominent Players
Nanoparticle Contract Manufacturing Market By Type of Nanoparticles-
Nanoparticle Contract Manufacturing Market By Manufacturing Scale-
Nanoparticle Contract Manufacturing Market By Application-
Nanoparticle Contract Manufacturing Market By End-user-
Nanoparticle Contract Manufacturing Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
